This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Anti-glomerular Basement Membrane Disease
Information about Anti-glomerular Basement Membrane Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Anti-glomerular Basement Membrane Disease
Most recent studies have shown that Anti-glomerular Basement Membrane Disease shares some biological mechanisms with autoimmune-diseases, autoimmune-reaction, crescentic-glomerulonephritis, glioblastoma, glomerulonephritis, hemoptysis, hemorrhage, hemosiderosis, kidney-diseases, kidney-failure, kidney-failure-chronic, lung-diseases, lupus-erythematosus-systemic, nephritis, proteinuria-of-undiagnosed-cause, pulmonary-hemorrhage, vasculitis, wegener-granulomatosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Anti-glomerular Basement Membrane Disease, and have been seen in publications frequently: Aging, Cell Activation, Cell Adhesion, Cell Cycle, Cell Proliferation, Coagulation, Complement Activation, Excretion, Glomerular Filtration, Humoral Immune Response, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Macrophage Activation, Pathogenesis, Phagocytosis, Platelet Aggregation, Secretion, Sensitization
Quite a number of genes have been found to play important roles in Anti-glomerular Basement Membrane Disease, such as ALB, C3, CCL2, CRP, CTLA4, FN1, ICAM1, IFNG, IL10, ITGB2, MPO, PRTN3, RNF130, SPP1, TNC, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.